20|20 OptimEyes Technologies is a biotechnology spin-out company from @McMasterU developing a transformative drug delivery platform for ocular diseases.
I thoroughly enjoyed participating in the final day of the #MBIbootcamp, especially the fireside chat featuring #brianbloom and #randypeterson. Brian's insights on the importance of de-risking and the positive shifts in the investment climate were particularly enlightening.
It was fantastic to engage with new investors and network with fellow innovators at two outstanding events within the Canadian entrepreneurial landscape. One particular highlight was the incredibly inspiring keynote address delivered by @EliCasdin@MintzGroup @bloomburton
Last week, I had the privilege of being invited to the Made at Mac Entrepreneurship showcase. The event included a dynamic panel discussion & innovation showcase, highlighting nearly 20 startup founders who have thrived within McMaster University's vibrant ecosystem of innovation
Thank you to @OISTWEETS for putting on a fantastic couple of days at the OIS XIII Ophthalmology Innovation Source in San Diego. Some great networking, great speakers, cutting-edge sessions, panel discussions, as well as seeing some familiar faces and collaborators. #OISXIIISummit
It was great to be at CPHI last week, very productive and lots of networking with potential partners with lots to follow up on. We look forward to attending again next year! #cphibarcelona#cphiworldwide#cphibarcelona2023#mcmaster university # facultyofengineering #optimeyes
Fran Lasowski and Renaud Jacquemart are currently at the 2023 BIO International Convention in Boston – find our company in the partnering system for potential meetings with us. Let’s come together to stand up for science! #standupforscience#bio2023#mcmasteruniversity#OptimEyes
Dr. Frances Lasowski, OptimEyes CEO and Dr. Renaud Jacquemart, OptimEyes COO will be at the Biomed Israel – 21st National Life Science & Technology Week Conference in Tel Aviv from today. Reach out if you’d like to connect! #BiomedIsrael#Biomedical#Research#McMasteruniversity
We are attending the Sixth Annual OBIO Investment Summit (Feb 8 – 10). Thanks to Maura Campbell for the warm welcome to what is proving to be an outstanding event. Thanks to all who made this opportunity possible. #leadership#innovation#transformation#startup#investinCanada
Participation the @DalInnovates program greatly accelerated our ability to continue to move our product from the lab to clinic to improve patient outcomes. Investment in commercialization training works!
Congrats to Dal Innovates alum @2020optimeyes on raising funds for their patented mucoadhesive micelle nanoparticle (MNP) technology, initially targeted for the treatment of glaucoma. 👏https://t.co/sr7t4InZ47
@DalInnovates Thanks for your support. It takes a village to raise a start-up and we have so many colleagues and programs that have helped us on this journey. Your expertise and mentorship is greatly appreciated!